Credit Suisse Initiates Prosensa With Neutral

Analysts at Credit Suisse initiated coverage on shares of Prosensa RNA with a Neutral rating. The target price for Prosensa is set to $9. Prosensa shares have gained 44.94% over the past 52 weeks, while the S&P 500 index has surged 17.13% in the same period. Prosensa's shares rose 1.93% to close at $8.45 yesterday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: InitiationAnalyst RatingsCredit Suisse
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!